(Health-NewsWire.Net, October 18, 2016 ) Publisher's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023" report provides an overview of the disease and global market size of the Celiac Disease for the 6MM (United States and EU5 countries (France, Germany, Italy, Spain and UK)). It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease from 2013-2023. Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection. Publisher forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to 4.69 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023). There is no targeted therapy approved for celiac disease. The current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases. Owing to the expected launch of Larazotide Acetate (Innovate Pharmaceuticals) in 2021 followed by the launch of Latiglutenase (ImmunogenX/Abbvie) in 2023, shall lead to a hike in the otherwise stable, worldwide market size of celiac disease. Publisher estimates suggest that the global market size is expected to grow at a CAGR of 19% from 2013-2023.
For more information about this report: http://www.reportsweb.com/celiac-disease-cd-market-insights-epidemiology-and-market-forecast-2023
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts. Scope - Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options. - It focuses on the detailed historical and forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for 6MM from 2013-2023. - The Report also includes historical and forecasted Market size of Celiac Disease for 6MM from 2013 to 2023. - It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details. - The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.
Table Of Content:- Report Introduction Celiac Disease Market Size Overview at a Glance Worldwide Market Size of Celiac Disease in 2013 Worldwide Market Size of Celiac Disease in 2023 Celiac Disease Overview Celiac Disease Types Non-Responsive or Refractory CD Etiology Symptoms Diagnosis Disease Management Disease Treatment Treatment of Celiac Disease Treatment of Non-Responsive or Refractory Celiac Disease (RCD) Current Unmet Medical Needs Epidemiology Parameters
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001426085/sample
Iceberg Model Genetic Predisposition Epidemiology &Patient Population United States Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023) EU5 Countries France Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023) Germany Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023) Italy Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023) Spain Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023) United Kingdom Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023) Emerging Phase III Therapies Larazotide acetate Product Description Regulatory Milestones Clinical Development Clinical Pipeline Activity Clinical Trial by Phase SWOT Analysis Latiglutenase Product Description Regulatory Milestones Clinical Development Clinical Pipeline Activity Clinical Trial by Phase SWOT Analysis AMG 714 Product Description Regulatory Milestones Clinical Development Clinical Pipeline Activity Clinical Trial by Phase SWOT Analysis Celiac Disease Market Size Global Market Size of Celiac Disease (2013-2023) Region-Wise Market size of Celiac Disease (2013-2023) United States Total Market Size of Celiac Disease (2013-2023) European Five Countries Italy Total Market Size of Celiac Disease (2013-2023) Germany Total Market Size of Celiac Disease (2013-2023) France Total Market Size of Celiac Disease(2013-2023) United Kingdom Total Market Size of Celiac Disease (2013-2023) Spain Total Market Size of Celiac Disease (2013-2023) Japan- Epidemiology and Market Size Market Drivers Market Barriers Appendix Report Methodology Consulting Services Disclaimer About DelveInsight
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001426085/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|